Combining Antiplatelet Drugs and Oral Anticoagulant Therapy in Atrial Fibrillation: Acute Coronary Syndromes and/or Percutaneous Coronary Intervention/Stenting Revisited-Reference-Cited by-同舟云学术

Combining Antiplatelet Drugs and Oral Anticoagulant Therapy in Atrial Fibrillation: Acute Coronary Syndromes and/or Percutaneous Coronary Intervention/Stenting Revisited

Published:2007-10 Issue:10 Volume:38 Page:
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Watson Timothy¹,Lip Gregory Y.H.¹

Affiliation:

1. University Department of Medicine, City Hospital, Birmingham, UK

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Link

https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.107.492488

Reference9 articles.

1. Combining Aspirin With Oral Anticoagulant Therapy

2. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis

3. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials

4. Anticoagulant (Fluindione)-Aspirin Combination in Patients with High-Risk Atrial Fibrillation

5. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized Medical Decision Making;Archives of Internal Medicine;2010-03-22

2. Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention?;Stroke;2009-05

3. Increased Major Bleeding Complications Related to Triple Antithrombotic Therapy Usage in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Artery Stenting;Chest;2008-09

4. 3,4-Dihydro-2H-1,4-benzoxazine Derivatives Combining Thrombin Inhibitory and Glycoprotein IIb/IIIa Receptor Antagonistic Activity as a Novel Class of Antithrombotic Compounds with Dual Function;Journal of Medicinal Chemistry;2008-08-27